Bhattacharjee, Nilabja https://orcid.org/0009-0007-7752-6990
Peela, Sreeram Chandra Murthy https://orcid.org/0000-0003-3379-6263
Halder, Abhishek https://orcid.org/0000-0003-0005-0254
Mathew, Bernadette https://orcid.org/0009-0005-8033-2965
Samanta, Swarnava
Gujral, Sakshi
Kumari, Stuti
Panda, Smruti
Ganguly, Ritwik
Ahuja, Gaurav https://orcid.org/0000-0002-2837-9361
De, Subhajyoti
Majumdar, Angshul
Sengupta, Debarka https://orcid.org/0000-0002-6353-5411
Funding for this research was provided by:
Indian Council of Medical Research (EMDR/IG/16/2024-01-01321)
Department of Biotechnology, Ministry of Science and Technology (IC-12044(12)/4/2022-ICD-DBT))
Department of Biotechnology, Ministry of Science and Technology (DBTHRDPMU/JRF/BET- 24/I/2024-25/306)
DST | Science and Engineering Research Board (CRG/2022/007706)
U.S. Department of Health & Human Services | National Institutes of Health (35GM149224)
Article History
Received: 29 August 2025
Accepted: 26 May 2026
First Online: 8 June 2026
Competing interests
: D.S. is a shareholder and Chief Science Officer in GeneSilico, a company focused on delivering precision oncology solutions. The remaining authors declare no competing interests.